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The Escherichia coli ribosomal proteins, L7/L12, are dominant over Ll 1 in modulating the binding of RF-I 
and RF-2 to ribosomes. The elevated activity of RF-2 on Ll l-lacking ribosomes over those containing Ll 1 
is abolished by IgG against L7/L12 or by removing the L7/L12 proteins. Adding back L7/L12 restores the 
original phenotype. The stimulatory factor, RF-3, is active on ribosomes depleted of L7/L12 but on those 
which lack Ll 1 the stimulatory effects are less pronounced or often not seen. RF-3 cannot restore activity 
with RF-I or RF-2 to ribosomes lacking both these sets of proteins. The stimulatory effects of an absence 
of either Ll 1 or RF-3 on the activity of RF-2 are not additive or synergistic. 
Release factor Ribosome Binding domain 
1. INTRODUCTION 2. EXPERIMENTAL 
The Escherichia colt’ ribosomal proteins L7/L12 
are required for the binding of the release factors 
RF-l and RF-2 [I ,2]. They are not absolutely 
essential, however, since at high concentrations of 
factor, ribosomes lacking L7/L12 support release 
factor activity which is insensitive to antibody 
against the L7/L12 proteins [3]. Recently Lll has 
been shown to modulate the binding of RF-l and 
RF-2 in a reciprocal manner; in the absence of Ll 1 
RF-2 has a markedly lower K,,, for binding into a 
termination complex while RF-l requires Lll for 
activity [4,5]. The important domain is in the N- 
terminal part of protein Ll 1 [5]. Previously RF-2 
was shown to crosslink with both L7/L12 and Ll 1 
[6]. Lll has been mapped by immunoelectron 
microscopy at the base of the L7/L12 stalk in the 
50 S subunit [7]. The release factor, RF-3, 
stimulates the activities of RF-l and RF-2 also by 
lowering their K,,, for binding into a termination 
complex with the ribosome [8,9]. 
We have examined how the stimulatory factor, 
RF-3, is affected by the ribosomal proteins L7/L12 
and Ll 1 and the relative contribution of these pro- 
teins to the binding domain of RF-l and RF-2. 
Ribosomes and release factors were isolated 
from E. coli MRE600 and purified as in [ 10,l l] or 
from the Ll l-lacking E. coli mutant AM 68 [5]. 
Ribosomal core particles and the supernatant pro- 
teins L7/L12 derived from the 70 S ribosome were 
prepared as reported [3]. The formation of a 
substrate complex and the assay in vitro of ter- 
mination dependent upon codon and release factor 
was essentially as described [111. A typical reaction 
contained in 0.05 ml: 50 mM Tris-OAc, pH 7.2, 
30 mM Mg(OAc)z, 75 mM NHdOAc, l-2 pg RF-2 
or 5 pg RF-l (purification stage V-l l), 70 pg RF-3, 
as indicated, 3-5 pmol of f[3H]Met-tRNA/AUG/ 
ribosome complex (4000 cpm/pmol), 0.08 &on,,, 
units of UAA, UGA or UAG. Incubations were 
for 30 min at 20°C. The f[3H]Met was extracted 
into ethyl acetate at pH 1. RF-3 activity was 
assayed essentially as in [8]. A typical reaction con- 
tained in 0.05 ml: 50 mM Tris-OAc, pH 7.2, 
30 mM Mg(OAc)z, 50 mM KCI, 3-5 pmol f[3H]- 
Met-tRNA/AUG/ribosome substrate (4000 cpm/ 
pmol), 1 pg RF-2, 5 ,ug RF-l, 70 ,eg RF-3 (purifica- 
tion fraction III-8), 0.05 Az~o,,,,, UAA or UAG or 
UGA. The IgG against L7/L12 was prepared as 
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previously described [3]. 
3. RESULTS AND DISCUSSION 
Ribosomes lacking L7/Ll2 were prepared from 
normal 70 S ribosomes and from ribosomes deriv- 
ed from an E. coli Ll l-lacking mutant [5]. This 
gave a choice of ribosomes: (a) with a full comple- 
ment of proteins, (b) with all proteins except 
L7/L12, (c) with all proteins except Lll and (d) 
with all proteins except L7/L12 and Lll. The 
relative activities of these ribosomes with RF-l and 
RF-2 are shown in fig.1. The control ribosomes 
showed activity with both factors which reflected 
the specific activity of each factor (panel a). The 
L7/L12 depleted ribosomes gave greatly reduced 
activity with both factors (panel b) while the 
Ll l-lacking ribosomes showed the expected highly 
elevated activity with RF-2 and low activity with 
CONTROL IAl _L7/Ll2 (61 
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Fig. 1. Activity of ribosomes depleted in L7/Ll2, or Lll 
or L7/Ll2/Lll with RF-l and RF-2. Ribosomes were 
prepared as described in section 2 and used to make 
substrates for in vitro termination. Each was assayed 
with increasing amounts of ( o---+) RF-l (7 pg/,4) or 
(O---O) RF-2 (2pg/& Backgrounds in the absence of 
release factor varied from 300-3000 and were subtracted 
in each case. (A) Control ribosomes, (B) ribosomes 
lacking L7/Ll2, (C) ribosomes lacking Lll, (D) 
Fig.2. Activity of ribosomes lacking Lll dependent 
upon L7/Ll2. (A) Ribosomes from the Lll-lacking 
mutant AM68 were used to make substrate for in vitro 
termination and assayed with (H) RF-l and 
(O---O) RF-2 in the presence of increasing amounts of 
IgG against L7/Ll2. A background in the absence of 
release factor (2000 cpm) was subtracted in each case. 
(B) Ribosomes from the Ll l-lacking mutant AM68 were 
depleted in L7/Ll2. The resulting cores were used to 
make substrate for in vitro termination and assayed with 
(M) RF-l and (O--O) RF-2 with increasing 
amounts of the L7/Ll2 protein fraction. A background 
in the absence of release factor (5000 cpm) was 
ribosomes lacking L7/Ll2 and Lll. subtracted in each case. 
RF-l (panel c). Ribosomes lacking L7/L12 and 
Ll 1 had essentially no activity with RF-l and poor 
activity with RF-2 (panel d). This indicates that the 
increased affinity of RF-2 for ribosomes lacking 
Lll (51 is drastically reduced when L7/L12 are 
removed and suggests that the modulation of RF-l 
and RF-2 binding at the domain by Lll is depen- 
dent upon an initial interaction for which L7/L12 
are necessary. A general conformational change in 
the binding domain for the factor rather than from 
a specific requirement of L7/L12 for the binding 
site could also cause this effect on removing 
L7/L12 from the Ll l-lacking ribosome. However, 
anti-L7/L12 had a similar effect on the activities of 
RF-l and RF-2 with Lll-lacking ribosomes as 
shown in fig.ZA, arguing against a non-specific 
conformational change at the domain when 
L7/L12 are removed. The loss of activity of 
L 11 -lacking ribosomes was reversible since it could 
be restored by titration of the L7/Ll2 proteins 
back onto the depleted ribosomal particle as shown 
in fig.2B. 
-LllRlBOSOMES [A) -L7/LWLIl RIBOSOMESI 
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The stimulation of RF-l and RF-2 activity by 
RF-3 previously reported [g] was confirmed as 
shown in fig.3 for both RF-l and RF-2 on 
ribosomes containing a full complement of pro- 
teins. When the ribosomes were depleted of 
L7/L12, RF-3 could stimulate the remaining ac- 
tivity of RF-2, and RF-l activity but reproducibly 
to a lesser degree. This indicates that RF-3 can still 
function on L7/L12 depleted ribosomes and sup- 
ports the assertion that there is a difference in the 
binding characteristics of RF-l and RF-2 at the do- 
main. Previously one fraction of an IgG against 
Ll 1 was shown to affect RF-l but not RF-2 while 
another fraction of the same antibody preparation 
affected RF-2 and not RF-l [5]. RF-3 was not able 
to restore activity to Lll-lacking ribosomes with 
RF-l and reproducibly had little or no effect on the 
activity of these ribosomes with RF-2. When 
L7/L12 and Lll were all missing from the 
ribosome there was no activity with either RF-l or 
I 
RF-2 
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Fig.3. Effect of RF-3 on activity of ribosomes depleted 
in L7/L12, or Lll or L7/L12/Lll. Ribosomes were 
prepared as described in section 2 and used to make 
substrate for in vitro termination. Each was assayed as 
described in a codon-dependent reaction with RF-2 
(2 pg) (upper panel) or RF-l (14pg) (lower panel) where 
50 mM K+ replaced the NH$ of the normal assay either 
with partially purified RF-3 (7Opg) (hatched bars), or 
without (open bars). Backgrounds in the absence of 
release factor (300-400 cpm) were subtracted in each 
Fig.4. The effect of RF-3 on RF-2 activity on 
Ll l-lacking ribosomes. (A) Ll l-lacking ribosomes were 
used to form substrate for codon-dependent in vitro 
termination and assayed at low concentrations of RF-2 
as indicated either under normal buffer conditions 
(75 mM NH:) in the presence of RF-3 (M) or in its 
absence (M) or under conditions optimal for RF-3 
stimulation (50 mM K+) in the presence of RF-3 (D---U) 
or in its absence (H). Backgrounds in the absence of 
release factor (600 cpm) were subtracted in each case. 
(B) Codon dependent termination was measured with 
Ll l-lacking ribosomes at low concentrations of RF-2 is 
indicated in the presence of IgG against L7/L12 in the 
presence of RF-3 (@--o) or its absence (8---+) under 
conditions optimal for RF-3 stimulation. Backgrounds 
in the absence of release factor (2000 cpm) were 
case. subtracted in each case. 
RF-2 and RF-3 had no effect (fig.3). The optimum 
conditions used here to observe the RF-3 stimula- 
tion of the in vitro termination reaction require K+ 
rather than NH; in the assay. Under these condi- 
tions Lll-lacking ribosomes had no activity with 
RF-l and L7/L12/Lll depleted ribosomes had no 
activity with RF-2 in contrast to the low activities 
seen with these ribosomes in the presence of NH: 
as in fig.1 and fig.%. 
The lack of an RF-3 effect seen with Ll l-lacking 
ribosomes could indicate a requirement for this 
protein to enable RF-3 to bind at the domain. We 
have investigated this possibility in two ways: first 
at low concentrations of factor RF-2, and second 
in the presence of anti-L7/L12. As shown in fig.4 
there was a small but reproducible stimulation of 
RF-2 activity with RF-3 at low concentrations of 
RF-2 when assayed with K+ (fig.4A-lower curves) 
although it is significantly lower than that seen 
with normal ribosomes (fig.3). No stimulation oc- 
RELEASE FACTOROJII 
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curred when assayed with NH; (fig.4A, upper 
curves). A definite stimulation of RF-2 activity 
with RF-3 was observed after treatment of the 
ribosome with anti-L7/L12 however; it indicates 
that RF-3 can indeed function on Lll depleted 
ribosomes (fig.4B). This effect is seen because of 
the dominance of the L7/L12 over Lll in 
modulating the binding of the release factors. 
Moreover it provides the first clear separation of 
the stimulatory effects of RF-3 and of a lack of 
Lll on the activity of RF-2. When L7/L12 is pre- 
sent then the lowered K,,, for RF-2 binding provid- 
ed by the absence of Ll 1 [4] masks a similar effect 
mediated by RF-3. 
The inability of the release factors to function 
on ribosomes lacking L7/L12 and Lll, observed 
under assay conditions optimal for RF-3 stimula- 
tion, was reexamined under the usual conditions 
for the termination assay in vitro, i.e., under op- 
timal conditions for RF-l and RF-2. As shown in 
table 1 there was stimulation of the other release 
factor activities by RF-3 with complete ribosomes. 
Removing L7/L12 resulted in RF-3 stimulating the 
low activities of RF-l and RF-2 consistent with the 
results of fig.3. No stimulation of RF-l activity on 
Ll l-lacking ribosomes was seen with RF-3 but any 
Table 1 
The effect of RF-3 on the activities of RF-l and RF-2 
with ribosomes or depleted cores 
Ribosomes RF-I RF-2 
70 s (f[‘H]Met released (Acpm)) 
Proteins RF-3 RF-3 RF-3 RF-3 
absent _ + - + 
None 7642 9571 7072 10288 
L7/L12 570 1153 623 1257 
Ll 1 (AM68) 290 283 11961 11869 
Ll 1 (AM76) 1560 1441 - - 
L7/L12/Lll 0 0 2109 1992 
Ribosomes with either L7/L12 and/or Lll absent as 
indicated were used to form substrate for in vitro 
termination and assayed in a codon-dependent reaction 
with RF-l (5-10 pug) and RF-2 (l-2 pg) dependent upon 
RF-3 (7Opg); under conditions optimal for RF-l and 
RF-2 activity (75 mM NH:) rather than for RF-3 
stimulation. Backgrounds in the absence of release 
factor varied from 300-2200 cpm were subtracted in 
each case 
possible effect on RF-2 was masked by the highly 
elevated activity of RF-2 alone. The Ll l-lacking 
mutant AM 76, whose ribosomes have higher ac- 
tivity with RF-l [5] also showed no stimulation 
with RF-3. Ribosomes lacking L7/L12/Lll had no 
activity with RF-I, some activity with RF-2, but no 
stimulation or restoration of activity was seen with 
RF-3. Given that RF-3 does stimulate RF-2 activity 
on Lll-lacking ribosomes in the presence of anti- 
L7/L12 the above result may indicate that removal 
of Lll/L7/L12 together from the release factor 
binding domain results in significant conforma- 
tional changes which interfere with RF-3 function. 
We have examined in a series of preliminary ex- 
periments the requirement of other ribosomal pro- 
teins for RF-3 activity at the release factor binding 
domain using 1.5 M LiCl depleted cores and a 
reconstitution protocol whereby a single protein is 
omitted [12]. Previously this approach has shown 
a requirement for L 16 in peptidyl-tRNA hydrolysis 
and in addition Lll and L7/L12 in codon- 
dependent termination [ 13,4]. However, to date no 
additional proteins have been observed to be re- 
quired for RF-3 function. 
Collectively the results suggest hat the L7/L12 
stalk structure, which is relatively exposed on the 
70 S ribosome as determined by immunoelectron 
microscopy [6] provides an initial recognition site 
for the release factors 1 and 2. This site may have 
a high affinity but relatively low specificity for 
release factors since the other protein synthesis fac- 
tors, EF-Tu and EF-G, also bind here [14,15]. 
Once the initial contact has been made then the 
specificity and affinity at a functional site may be 
mediated by other components, such as protein 
Ll 1 in the domain itself or external factors such as 
RF-3. RF-l and RF-2 apparently recognise the ter- 
mination codons at the A site and although their 
binding domain does not overlap with the tRNA 
binding site it overlaps with that of EF-Tu [la]. It 
has not yet been established whether the 
L7/L12/Lll binding domain and the codon 
recognition domain are indeed the same. The A 
site has been inferred to be far from the L7/L12 
stalk from a number of studies but recently 
authors in [17] have argued persuasively that the A 
site is in a groove quite near the L7/Ll2 stalk. Our 
studies on the RF binding domains are more con- 
sistent with such a placement. How the release fac- 
tor influences the peptidyltransferase centre, also 
93 
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inferred to be far from the RF binding domain, is 
unclear at present. 
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